Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Magnetic resonance-guided histopathology for improved accuracy of tumor response evaluation of neoadjuvant treatment in organ-infiltrating rectal cancer.

Hole KH, Larsen SG, Grøholt KK, Giercksky KE, Ree AH.

Radiother Oncol. 2013 May;107(2):178-83. doi: 10.1016/j.radonc.2013.03.017. Epub 2013 Apr 17.

PMID:
23602370
2.

Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.

Kim SH, Lee JM, Hong SH, Kim GH, Lee JY, Han JK, Choi BI.

Radiology. 2009 Oct;253(1):116-25. doi: 10.1148/radiol.2532090027.

PMID:
19789256
3.

Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer.

Kim YH, Kim DY, Kim TH, Jung KH, Chang HJ, Jeong SY, Sohn DK, Choi HS, Ahn JB, Kim DH, Lim SB, Lee JS, Park JG.

Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):761-8.

PMID:
15936557
4.

Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation.

Chang GJ, You YN, Park IJ, Kaur H, Hu CY, Rodriguez-Bigas MA, Skibber JM, Ernst RD.

Dis Colon Rectum. 2012 Apr;55(4):371-7. doi: 10.1097/DCR.0b013e31824678e3.

5.

Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?

Dresen RC, Beets GL, Rutten HJ, Engelen SM, Lahaye MJ, Vliegen RF, de Bruïne AP, Kessels AG, Lammering G, Beets-Tan RG.

Radiology. 2009 Jul;252(1):71-80. doi: 10.1148/radiol.2521081200. Epub 2009 Apr 29.

PMID:
19403847
6.

MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?

Yu SK, Tait D, Chau I, Brown G.

Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):505-11. doi: 10.1016/j.ijrobp.2013.06.2052.

PMID:
24074924
7.

Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.

Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Feig B, Nguyen S, Hu CY, Chang GJ.

Dis Colon Rectum. 2013 Feb;56(2):135-41. doi: 10.1097/DCR.0b013e318278ff8a.

8.
9.
10.

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.

Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, Tebbutt N, Hill M, Ross PJ, Massey A, Oates J.

J Clin Oncol. 2006 Feb 1;24(4):668-74.

11.

MAGNETIC RESONANCE IMAGING TO EVALUATE NEOADJUVANT THERAPY EFFECTS ON RECTAL CARCINOMA.

Sofić A, Vukobrat-Bijedić Z, Husić-Selimović A, Šehović N, Buija D, Eminagić D, Banjin M, Đuran A.

Acta Clin Croat. 2015 Sep;54(3):303-8.

PMID:
26666099
12.

Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Kim SH, Lee JM, Park HS, Eun HW, Han JK, Choi BI.

J Magn Reson Imaging. 2009 May;29(5):1093-101. doi: 10.1002/jmri.21742.

PMID:
19388124
13.

Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience.

Nougaret S, Fujii S, Addley HC, Bibeau F, Pandey H, Mikhael H, Reinhold C, Azria D, Rouanet P, Gallix B.

J Magn Reson Imaging. 2013 Sep;38(3):726-32. doi: 10.1002/jmri.23905. Epub 2012 Nov 13.

PMID:
23152299
14.

Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy.

Smith FM, Wiland H, Mace A, Pai RK, Kalady MF.

Dis Colon Rectum. 2014 Mar;57(3):311-5. doi: 10.1097/DCR.0b013e3182a84eba.

PMID:
24509452
15.

Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.

Jung SH, Heo SH, Kim JW, Jeong YY, Shin SS, Soung MG, Kim HR, Kang HK.

J Magn Reson Imaging. 2012 Jan;35(1):110-6. doi: 10.1002/jmri.22749. Epub 2011 Oct 11.

PMID:
21989997
16.

Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683).

Perez RO, Habr-Gama A, Gama-Rodrigues J, Proscurshim I, Julião GP, Lynn P, Ono CR, Campos FG, Silva e Sousa AH Jr, Imperiale AR, Nahas SC, Buchpiguel CA.

Cancer. 2012 Jul 15;118(14):3501-11. doi: 10.1002/cncr.26644. Epub 2011 Nov 15.

17.

CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.

Wallin U, Rothenberger D, Lowry A, Luepker R, Mellgren A.

Dis Colon Rectum. 2013 Jul;56(7):859-68. doi: 10.1097/DCR.0b013e31828e5a72.

PMID:
23739192
18.

Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT.

Ippolito D, Monguzzi L, Guerra L, Deponti E, Gardani G, Messa C, Sironi S.

Abdom Imaging. 2012 Dec;37(6):1032-40. doi: 10.1007/s00261-011-9839-1.

PMID:
22270580
19.

MRI features of the complete histopathological response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.

Franklin JM, Anderson EM, Gleeson FV.

Clin Radiol. 2012 Jun;67(6):546-52. doi: 10.1016/j.crad.2011.11.004. Epub 2012 Jan 2.

PMID:
22218409
20.

Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies.

Belluco C, De Paoli A, Canzonieri V, Sigon R, Fornasarig M, Buonadonna A, Boz G, Innocente R, Perin T, Cossaro M, Polesel J, De Marchi F.

Ann Surg Oncol. 2011 Dec;18(13):3686-93. doi: 10.1245/s10434-011-1822-0. Epub 2011 Jun 21.

Items per page

Supplemental Content

Write to the Help Desk